Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015 (2015), Article ID 405217, 5 pages
http://dx.doi.org/10.1155/2015/405217
Research Article

Association Analysis of MET Gene Polymorphism with Papillary Thyroid Carcinoma in a Chinese Population

1Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, China
2National Research Institute for Family Planning, Beijing 100081, China
3Jilin Provincial Key Laboratory of Surgical Translational Medicine, Department of Thyroid and Parathyroid Surgery, China-Japan Union Hospital, Jilin University, Changchun 130033, China

Received 10 June 2015; Revised 16 October 2015; Accepted 27 October 2015

Academic Editor: Diego Russo

Copyright © 2015 Lifeng Ning et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. L. Meinhold, E. Ron, S. J. Schonfeld et al., “Nonradiation risk factors for thyroid cancer in the US radiologic technologists study,” American Journal of Epidemiology, vol. 171, no. 2, pp. 242–252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Kondo, S. Ezzat, and S. L. Asa, “Pathogenetic mechanisms in thyroid follicular-cell neoplasia,” Nature Reviews Cancer, vol. 6, no. 4, pp. 292–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. DeLellis, “Pathology and genetics of thyroid carcinoma,” Journal of Surgical Oncology, vol. 94, no. 8, pp. 662–669, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Pacak, D. C. Sweeney, L. Wartofsky et al., “Solitary cerebellar metastasis from papillary thyroid carcinoma: a case report,” Thyroid, vol. 8, no. 4, pp. 327–335, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Leux, T. Truong, C. Petit, D. Baron-Dubourdieu, and P. Gúenel, “Family history of malignant and benign thyroid diseases and risk of thyroid cancer: a population-based case—control study in New Caledonia,” Cancer Causes and Control, vol. 23, no. 5, pp. 745–755, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Dal Maso, C. Bosetti, C. La Vecchia, and S. Franceschi, “Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors,” Cancer Causes and Control, vol. 20, no. 1, pp. 75–86, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Lun, X. Wu, Q. Xia et al., “Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis,” Otolaryngology&Head and Neck Surgery, vol. 148, no. 3, pp. 396–402, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Rago, E. Fiore, M. Scutari et al., “Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease,” European Journal of Endocrinology, vol. 162, no. 4, pp. 763–770, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Q. Zhang, F. Song, H. Zheng et al., “Association between single-nucleotide polymorphisms of BRAF and papillary thyroid carcinoma in a Chinese population,” Thyroid, vol. 23, no. 1, pp. 38–44, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Damiola, G. Byrnes, M. Moissonnier et al., “Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation,” International Journal of Cancer, vol. 134, no. 7, pp. 1659–1668, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. G. G. Chen, Q. Zeng, and G. M. K. Tse, “Estrogen and its receptors in cancer,” Medicinal Research Reviews, vol. 28, no. 6, pp. 954–974, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Rahbari, L. Zhang, and E. Kebebew, “Thyroid cancer gender disparity,” Future Oncology, vol. 6, no. 11, pp. 1771–1779, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. K. H. Jung, B. H. Park, and S.-S. Hong, “Progress in cancer therapy targeting c-Met signaling pathway,” Archives of Pharmacal Research, vol. 35, no. 4, pp. 595–604, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Trusolino and P. M. Comoglio, “Scatter-factor and semaphorin receptors: cell signalling for invasive growth,” Nature Reviews Cancer, vol. 2, no. 4, pp. 289–300, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. P. C. Ma, G. Maulik, J. Christensen, and R. Salgia, “c-Met: structure, functions and potential for therapeutic inhibition,” Cancer and Metastasis Reviews, vol. 22, no. 4, pp. 309–325, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Schmidt, F.-M. Duh, F. Chen et al., “Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas,” Nature Genetics, vol. 16, no. 1, pp. 68–73, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Jeffers, M. Fiscella, C. P. Webb, M. Anver, S. Koochekpour, and G. F. Vande Woude, “The mutationally activated Met receptor mediates motility and metastasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 24, pp. 14417–14422, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Lorenzato, M. Olivero, S. Patané et al., “Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion,” Cancer Research, vol. 62, no. 23, pp. 7025–7030, 2002. View at Google Scholar · View at Scopus
  19. M. F. Di Renzo, M. Olivero, T. Martone et al., “Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas,” Oncogene, vol. 19, no. 12, pp. 1547–1555, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. D. S. Cooper, G. M. Doherty, B. R. Haugen et al., “Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 19, no. 11, pp. 1167–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Sunakawa, T. Wakatsuki, D. Yang et al., “Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients,” Pharmacogenetics and Genomics, vol. 24, no. 12, pp. 588–596, 2014. View at Publisher · View at Google Scholar
  22. F. A. Schutz, M. M. Pomerantz, K. P. Gray et al., “Prospective analysis of genetic polymorphisms and risk of recurrence in renal cell cancer,” The Lancet Oncology, vol. 14, no. 1, pp. 81–87, 2013. View at Google Scholar
  23. A. Levy and E. Freidman, “Methods for detecting an increased susceptibility to cancer,” Google Patents, 2009.
  24. S. Duan, S. Mi, W. Zhang, and M. E. Dolan, “Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes,” RNA Biology, vol. 6, no. 4, pp. 412–425, 2009. View at Google Scholar · View at Scopus
  25. S. Tchatchou, A. Jung, K. Hemminki et al., “A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women,” Carcinogenesis, vol. 30, no. 1, pp. 59–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. J. Yang, L. Y. Cho, K.-P. Ko et al., “Genetic susceptibility on caga-interacting molecules and gene-environment interaction with phytoestrogens: a putative risk factor for gastric cancer,” PLoS ONE, vol. 7, no. 2, Article ID e31020, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. N. U. Din, O. C. Ukoumunne, G. Rubin et al., “Age and gender variations in cancer diagnostic intervals in 15 cancers: analysis of data from the UK Clinical Practice Research Datalink,” PLoS ONE, vol. 10, no. 5, Article ID e0127717, 2015. View at Publisher · View at Google Scholar
  28. J. Ortega, C. Sala, B. Flor, and S. Lledo, “Efficacy and cost-effectiveness of the UltraCision harmonic scalpel in thyroid surgery: an analysis of 200 cases in a randomized trial,” Journal of Laparoendoscopic & Advanced Surgical Techniques Part A, vol. 14, no. 1, pp. 9–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Rahbari, L. Zhang, and E. Kebebew, “Is there a molecular basis for cancer gender disparity?” Journal of Surgical Research, vol. 165, no. 2, pp. 220–221, 2011. View at Google Scholar
  30. Q. Zeng, G. G. Chen, A. C. Vlantis, and C. A. van Hasselt, “Estrogen and apoptosis in thyroid cancer,” in Oncogene Proteins: New Research, pp. 289–309, Nova Science, 2008. View at Google Scholar
  31. J. Nitzkorski, F. Zhu, C. Loveland-Jones et al., “Breast cancer histology and the influence of the hormonal milieu,” Journal of Surgical Research, vol. 165, no. 2, p. 220, 2011. View at Publisher · View at Google Scholar
  32. M. J. Schlumberger, “Papillary and follicular thyroid carcinoma,” The New England Journal of Medicine, vol. 338, no. 5, pp. 297–306, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. T. D. S. Mitteldorf, J. M. De Sousa-Canavez, K. R. M. Leite, C. Massumoto, and L. H. Camara-Lopes, “FN1, GALE, MET, and QPCT overexpression in papillary thyroid carcinoma: molecular analysis using frozen tissue and routine fine-needle aspiration biopsy samples,” Diagnostic Cytopathology, vol. 39, no. 8, pp. 556–561, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. H. C. Nardone, A. F. Ziober, V. A. LiVolsi et al., “C-Met expression in tall cell variant papillary carcinoma of the thyroid,” Cancer, vol. 98, no. 7, pp. 1386–1393, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. E. H. Lim, S.-L. Zhang, J.-L. Li et al., “Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC),” Journal of Thoracic Oncology, vol. 4, no. 1, pp. 12–21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Schmid, S. Burock, K. Klockmeier, P. M. Schlag, and U. Stein, “SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer,” Molecular Cancer, vol. 11, article 49, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Gumustekin, A. Kargi, G. Bulut et al., “HGF/c-Met overexpressions, but not met mutation, correlates with progression of non-small cell lung cancer,” Pathology and Oncology Research, vol. 18, no. 2, pp. 209–218, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. V.-M. Wasenius, S. Hemmer, M.-L. Karjalainen-Lindsberg, N. N. Nupponen, K. Franssila, and H. Joensuu, “MET receptor tyrosine kinase sequence alterations in differentiated thyroid carcinoma,” The American Journal of Surgical Pathology, vol. 29, no. 4, pp. 544–549, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Castano, Y. Bossé, L. M. Endam, A. Filali-Mouhim, and M. Desrosiers, “C-MET pathway involvement in chronic rhinosinusitis: a genetic association analysis,” Otolaryngology—Head and Neck Surgery, vol. 142, no. 5, pp. 665–671, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Gandolfi, D. De Biase, V. Sancisi et al., “Deep sequencing of KIT, MET, PIK3CA, and PTEN hotspots in papillary thyroid carcinomas with distant metastases,” Endocrine-Related Cancer, vol. 21, no. 5, pp. L23–L26, 2014. View at Publisher · View at Google Scholar · View at Scopus